bioMerieux S.A. Stock
Your prediction
bioMerieux S.A. Stock
We can see a decrease in the price for bioMerieux S.A.. Compared to yesterday it has lost -€1.900 (-1.710%).
So far the community has only identified positive things for bioMerieux S.A. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of bioMerieux S.A. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of bioMerieux S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| bioMerieux S.A. | -1.710% | 0.921% | -0.364% | 7.451% | 6.511% | 13.176% | -5.599% |
| EssilorLuxottica SA | -1.530% | -2.067% | -13.871% | 15.873% | 15.280% | 58.277% | 111.263% |
| Sartorius Stedim Biotech S.A. | -0.430% | 1.176% | 2.839% | 10.605% | 12.381% | -31.213% | -28.547% |
| Henry Schein Inc. | 0.360% | -1.218% | -0.031% | -3.566% | -2.728% | -14.470% | 19.104% |
Comments
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Show more
Ratings data for BMXMF provided by MarketBeat
